News stories about Analogic Corporation (NASDAQ:ALOG) have been trending somewhat positive this week, Accern reports. Accern scores the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Analogic Corporation earned a news impact score of 0.15 on Accern’s scale. Accern also gave headlines about the medical research company an impact score of 45.1369812435201 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
These are some of the headlines that may have impacted Accern’s scoring:
- Analogic Corporation (ALOG) Insider James Patrick Ryan Sells 180 Shares (americanbankingnews.com)
- Analogic’s ConneCT Checkpoint CT Scanner to Make its Debut for the Americas at Future Travel Experience Global 2017 (feeds.benzinga.com)
- Analogic’s ConneCT Checkpoint CT Scanner to Make its Debut for the Americas at Future Travel Experience Global 2017 (finance.yahoo.com)
- Analogic Corporation (ALOG) and Novadaq Technologies (NVDQ) Financial Comparison (americanbankingnews.com)
- Analogic Corp. breached its 50 day moving average in a Bullish Manner : ALOG-US : August 14, 2017 (finance.yahoo.com)
Shares of Analogic Corporation (ALOG) traded up 0.36% during trading on Friday, reaching $69.50. 161,966 shares of the company were exchanged. The stock’s market capitalization is $866.67 million. Analogic Corporation has a 52-week low of $66.00 and a 52-week high of $95.85. The stock has a 50-day moving average of $70.79 and a 200 day moving average of $73.32.
Analogic Corporation (NASDAQ:ALOG) last announced its quarterly earnings data on Tuesday, June 6th. The medical research company reported $0.79 EPS for the quarter, beating the Zacks’ consensus estimate of $0.74 by $0.05. The firm had revenue of $122.16 million during the quarter, compared to analysts’ expectations of $121.35 million. Analogic Corporation had a positive return on equity of 6.75% and a negative net margin of 7.97%. The company’s revenue for the quarter was down 4.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.80 earnings per share. On average, equities analysts anticipate that Analogic Corporation will post $2.60 earnings per share for the current fiscal year.
Separately, Jefferies Group LLC started coverage on shares of Analogic Corporation in a report on Wednesday, August 9th. They set a “hold” rating and a $75.00 target price on the stock. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $87.00.
About Analogic Corporation
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corporation and related companies with our FREE daily email newsletter.